The present invention relates to benzofurane and benzothiophene derivatives of formula (I)
wherein (R1)n, R2, R3, R4a, R4b, R5a, R5b and Ar1 are as described in the description and their use in the treatment of cancer by modulating an immune response comprising a reactivation of the immune system in the tumor. The invention further relates to novel benzofurane and benzothiophene derivatives of formula (II) and their use as pharmaceuticals, to their preparation, to pharmaceutically acceptable salts thereof, and to their use as pharmaceuticals, to pharmaceutical compositions containing one or more compounds of formula (I), and especially to their use as modulators of the prostaglandin 2 receptors EP2 and/or EP4.
本发明涉及式 (I) 的
苯并呋喃和
苯并噻吩衍
生物
其中(R1)n、R2、R3、R4a、R4b、R5a、R5b 和 Ar1 如说明书所述,以及它们通过调节免疫反应(包括重新激活肿瘤中的免疫系统)治疗癌症的用途。本发明进一步涉及式(II)的新型
苯并呋喃和
苯并噻吩衍
生物及其作为药物的用途、它们的制备、它们的药学上可接受的盐及其作为药物的用途、含有一种或多种式(I)化合物的药物组合物,特别是它们作为
前列腺素2受体EP2和/或EP4的调节剂的用途。